Clinical trial
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar…
NCT00202397 · S. Andrea Hospital, Other · Completed
Key facts
| NCT number | NCT00202397 |
|---|---|
| Title | Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia |
| Official title | Phase 2 Study of Riluzole Effects on Patients With Chronic Cerebellar Ataxia |
| Lead sponsor | S. Andrea Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hereditary Ataxia, Multiple Sclerosis, Cerebellar Ataxia |
| Intervention type | Drug, Other |
| Interventions | Riluzole, placebo |
| Enrollment | 40 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 2, 2024 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: